Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Low-dose glucagon for prevention of exercise-induced hypoglycemia in type 1 diabetes
2021-001342-34Phase 2Completed
- Sponsor
- Steno Diabetes Center Copenhagen
- Start
- Jun 2021
- Modality
- Recombinant Proteins and Enzymes, Peptides
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of glucagon in diabetes mellitus type 1 (T1D) and hypoglycaemia (3 arms), sponsored by Steno Diabetes Center Copenhagen. Started Jun 2021; status: completed.
02
Drugs
glucagon
03
Conditions
diabetes mellitus type 1 (T1D)hypoglycaemia
Beyond the preview
Go deeper on 2021-001342-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2021-001342-34.